Allworth Financial’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$450	Buy	30 +17	+131%	+$255	﹤0.01%	4156
2025 Q1	$195	Buy	13 +4	+44%	+$60	﹤0.01%	3869
2024 Q4	$197	Buy	9 +2	+29%	+$44	﹤0.01%	3787
2024 Q3	$206	Buy	+7	New	+$206	﹤0.01%	3590